Argentina’s Richmond company continues to prepare for a full-cycle production of the Russian Sputnik V vaccine, the Clarin newspaper reported.
Its source, commenting on the situation around the full-cycle production of Sputnik V and other vaccines at the company’s new factory, said that the "activity on technology transfer was not suspended." According to the source, the factory will launch operations "this October or November."
The source said that the company is also considering producing vaccines "both from the US and from Europe and Asia" at the new factory.
Before the new factory opens, Richmond may produce Sputnik V from the active substance sent from Russia. According to the newspaper, currently the company has suspended production because the government is not sending new requests for Sputnik V. "We have 1.4 mln doses of the vaccine stored and we can produce more when asked," the source said.
